Evidence map›Paper›PMID 29416250›Full record

ArticleJournal of anaesthesiology, clinical pharmacology

A study of the efficacy of stellate ganglion blocks in complex regional pain syndromes of the upper body.

Rashmi Datta, Jyotsna Agrawal, Amit Sharma, Vikram Singh Rathore, Shivesh Datta

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of anaesthesiology, clinical pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05638620 (Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05638620 phase1completednot on this map

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

TypeinterventionalSponsorJonathann Kuo, MDRan2023 to 2023Enrolled20ConditionsPost Acute COVID-19 Syndrome, Long COVID, Long Covid19, COVID-19 RecurrentArmsstellate ganglion block with 0.5% bupivacaine
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Is CRPS-1 a Chronic Disabling Disease? A Long-term, Real-Life Study on Patients Treated With Neridronate.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rashmi DattaDepartment of Anaesthesiology and Critical Care, Base Hospital Delhi Cantt and Army College of Medical Sciences, New Delhi, India.
Jyotsna AgrawalDepartment of Anaesthesiology and Critical Care, Base Hospital Delhi Cantt and Army College of Medical Sciences, New Delhi, India.
Amit SharmaDepartment of Anaesthesiology and Critical Care, Base Hospital Delhi Cantt and Army College of Medical Sciences, New Delhi, India.
Vikram Singh RathoreDepartment of Anaesthesiology and Critical Care, Base Hospital Delhi Cantt and Army College of Medical Sciences, New Delhi, India.
Shivesh DattaDepartment of Anaesthesiology and Critical Care, Base Hospital Delhi Cantt and Army College of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsThe effect of stellate ganglion blocks (SGBs) was examined in complex regional pain syndromes (CRPS) of the upper body. MATERIAL AND

methodsA total of 287 SGB were given to patients with documented CRPS on medications. Spontaneous and provoked pain assessment was done with numeric pain rating scale (NPRS). The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and range of motion (ROM) was recorded before and after each blockade. Difference between a 15-point "global rating of change" scale determined the minimal clinically important difference of the DASH score.

resultsThe overall mean pain reduction was 73.2% (

conclusionsSGB are relatively safe and effective management in patients with neuropathic conditions already on pharmacotherapy. Serial blocks attained an average reduction in pain by >3 NPRS points from the baseline for both spontaneous and provoked pain with a decrease in mean DASH score and improvement in ROM.

Indexed as

Complex regional pain syndromesstellate ganglion blocksupper limb

Identifiers

PMID29416250
PMCPMC5791271
OpenAlexW2786422872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.